Positive results from new study on influenza
An in vitro study from the Medical University of Innsbruck shows that ColdZyme breaks the viral infection cycle and significantly reduces the viral load in human cells infected with influenza A. Enzymatica’s CEO Claus Egstrand visited BioStock’s studio to talk about ColdZyme and the study results.